Lipid lowering with inclisiran: a real-world single-centre experience. (2022)

First Author: Padam P
Attributed to:  Ligand bias at the GLP-1 receptor as a means of favouring cytoprotection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/openhrt-2022-002184

PubMed Identifier: 36600646

Publication URI: http://europepmc.org/abstract/MED/36600646

Type: Journal Article/Review

Volume: 9

Parent Publication: Open heart

Issue: 2

ISSN: 2053-3624